UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 253

Sortiert nach

Haemolysis during sample preparation alters microRNA content of plasma

PloS one, 2011-09, Vol.6 (9), p.e24145-e24145

2011

Volltextzugriff (PDF)

Asbestos-related cancers: the 'Hidden Killer' remains a global threat

Expert review of anticancer therapy, 2020-04, Vol.20 (4), p.271-278

2020

Volltextzugriff (PDF)

Validity of predictive equations for total energy expenditure against doubly labeled water

Scientific reports, 2024-07, Vol.14 (1), p.15754-10, Article 15754

2024

Volltextzugriff (PDF)

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2017-09, Vol.12 (9), p.1421-1433

2017

Volltextzugriff (PDF)

Manipulating microRNAs for the Treatment of Malignant Pleural Mesothelioma: Past, Present and Future

Frontiers in oncology, 2020-02, Vol.10, p.105-105

2020

Volltextzugriff (PDF)

The Impact of Hemolysis on Cell-Free microRNA Biomarkers

Frontiers in genetics, 2013, Vol.4, p.94-94

2013

Volltextzugriff (PDF)

Non-coding RNAs as potential biomarkers and therapeutic targets in polycystic kidney disease

Frontiers in physiology, 2022-09, Vol.13, p.1006427-1006427

2022

Volltextzugriff (PDF)

Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers

Journal of Clinical Pathology, 2013-10, Vol.66 (10), p.847-853

2013

Volltextzugriff (PDF)

Editorial: Emerging Therapies for Malignant Mesothelioma

Frontiers in oncology, 2020-06, Vol.10, p.939-939

2020

Volltextzugriff (PDF)

Cilengitide inhibits attachment and invasion of malignant pleural mesothelioma cells through antagonism of integrins αvβ3 and αvβ5

PloS one, 2014-03, Vol.9 (3), p.e90374-e90374

2014

Volltextzugriff (PDF)

Validation of predictive equations to estimate resting metabolic rate of females and males across different activity levels

American journal of human biology, 2024-04, Vol.36 (4), p.e24005-n/a

2024

Volltextzugriff (PDF)

The Potential Links between lncRNAs and Drug Tolerance in Lung Adenocarcinoma

Genes, 2024-07, Vol.15 (7), p.906

2024

Volltextzugriff (PDF)

Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2018-02, Vol.13 (2), p.258-272

2018

Volltextzugriff (PDF)

YB‐1 regulates mesothelioma cell migration via snail but not EGFR, MMP1, EPHA5 or PARK2

Molecular oncology, 2024-04, Vol.18 (4), p.815-831

2024

Volltextzugriff (PDF)

Why Be One Protein When You Can Affect Many? The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma

Frontiers in cell and developmental biology, 2019-10, Vol.7, p.221-221

2019

Volltextzugriff (PDF)

YB-1, the E2F Pathway, and Regulation of Tumor Cell Growth

JNCI : Journal of the National Cancer Institute, 2012-01, Vol.104 (2), p.133-146

2012

Volltextzugriff (PDF)

Small and Large Extracellular Vesicles Derived from Pleural Mesothelioma Cell Lines Offer Biomarker Potential

Cancers, 2023-04, Vol.15 (8), p.2364

2023

Volltextzugriff (PDF)

An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer

Journal of clinical medicine, 2018-06, Vol.7 (6), p.153

2018

Volltextzugriff (PDF)

A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma

Molecular oncology, 2018-01, Vol.12 (1), p.58-73

2018

Volltextzugriff (PDF)

KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma

Molecular cancer, 2016-06, Vol.15 (1), p.44-44, Article 44

2016

Volltextzugriff (PDF)

Exploring MicroRNA and Exosome Involvement in Malignant Pleural Mesothelioma Drug Response

Cancers, 2022-09, Vol.14 (19), p.4784

2022

Volltextzugriff (PDF)

Characterization of the Transport of Nucleoside Analog Drugs by the Human Multidrug Resistance Proteins MRP4 and MRP5

Molecular pharmacology, 2003-05, Vol.63 (5), p.1094-1103

2003

Volltextzugriff (PDF)

Loss of miR-223 and JNK Signaling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma

Molecular cancer research, 2015-07, Vol.13 (7), p.1106-1118

2015

Volltextzugriff (PDF)

Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4)

Biochemical journal, 2003-04, Vol.371 (Pt 2), p.361-367

2003

Volltextzugriff (PDF)

MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets

Journal of thoracic disease, 2015-06, Vol.7 (6), p.1031-1040

Reid, Glen

2015

Volltextzugriff (PDF)

1 – 25 von 253

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(225)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(253)
Japanisch
(41)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Haemolysis during sample preparation alters microRNA content of plasma

Asbestos-related cancers: the 'Hidden Killer' remains a global threat

Validity of predictive equations for total energy expenditure against doubly labeled water

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Manipulating microRNAs for the Treatment of Malignant Pleural Mesothelioma: Past, Present and Future

The Impact of Hemolysis on Cell-Free microRNA Biomarkers

Non-coding RNAs as potential biomarkers and therapeutic targets in polycystic kidney disease

Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers

Editorial: Emerging Therapies for Malignant Mesothelioma

Cilengitide inhibits attachment and invasion of malignant pleural mesothelioma cells through antagonism of integrins αvβ3 and αvβ5

Validation of predictive equations to estimate resting metabolic rate of females and males across different activity levels

The Potential Links between lncRNAs and Drug Tolerance in Lung Adenocarcinoma

Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma

YB‐1 regulates mesothelioma cell migration via snail but not EGFR, MMP1, EPHA5 or PARK2

Why Be One Protein When You Can Affect Many? The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma

YB-1, the E2F Pathway, and Regulation of Tumor Cell Growth

Small and Large Extracellular Vesicles Derived from Pleural Mesothelioma Cell Lines Offer Biomarker Potential

An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer

A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma

KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma

Exploring MicroRNA and Exosome Involvement in Malignant Pleural Mesothelioma Drug Response

Characterization of the Transport of Nucleoside Analog Drugs by the Human Multidrug Resistance Proteins MRP4 and MRP5

Loss of miR-223 and JNK Signaling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma

Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4)

MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets

Suchergebnisse filtern